The smaller the particle size of Ag nanoparticles, the higher their antibacterial activity against drug-resistant strains, and the greater their potential for application in living organisms. Therefore, preparing Ag nanoparticles with ultra-small particle sizes has become one of the greatest challenges at present. In this study, 1.75 nm Ag was uniformly anchored on the surface of a highly biocompatible carrier to synthesize Fe3O4/ZnO@Cu2S@Ag (FCA) nanocomposites. The antibacterial activity and mechanism of FCA were investigated, and the material was used to treat wound infections caused by bacteria. At a concentration of 175 μg/mL, the antibacterial rate of Escherichia coli, Staphylococcus aureus, and drug-resistant Salmonella was over 99.99 % within 45 min. The antibacterial activity is mainly composed of •OH and multiple cations. The antibacterial mechanism involves •OH and multiple cations synergistically targeting and damaging the bacterial cell wall, altering the secondary structure of the bacterial cell wall, leading to leakage of bacterial contents and bacterial death. Additionally, FCA exhibited high biocompatibility, curing bacterial infections within 7 days and completely eliminating bacterial burden. These findings elucidate the role of antibacterial activity in composite antibacterial materials and suggest that FCA has clinical application potential in treating bacterial infections.
Read full abstract